1. Home
  2. NICE vs CAI Comparison

NICE vs CAI Comparison

Compare NICE & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NICE Ltd

NICE

NICE Ltd

HOLD

Current Price

$88.21

Market Cap

5.6B

Sector

Technology

ML Signal

HOLD

CAI

Caris Life Sciences Inc.

HOLD

Current Price

$17.82

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NICE
CAI
Founded
1986
2008
Country
Israel
United States
Employees
9626
1846
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
4.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NICE
CAI
Price
$88.21
$17.82
Analyst Decision
Buy
Strong Buy
Analyst Count
13
11
Target Price
$153.46
$30.91
AVG Volume (30 Days)
710.4K
3.0M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$10.14
$25.24
Revenue Next Year
$9.62
$22.32
P/E Ratio
$11.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$84.38
$14.19
52 Week High
$175.00
$42.50

Technical Indicators

Market Signals
Indicator
NICE
CAI
Relative Strength Index (RSI) 38.90 55.69
Support Level $86.40 $17.21
Resistance Level $116.83 $19.79
Average True Range (ATR) 3.94 1.08
MACD -0.15 0.29
Stochastic Oscillator 19.06 93.64

Price Performance

Historical Comparison
NICE
CAI

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

About CAI Caris Life Sciences Inc.

Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.

Share on Social Networks: